Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 1;60(5):2232-2256.
doi: 10.1002/anie.201915826. Epub 2020 Sep 24.

Smart Design of Nanomaterials for Mitochondria-Targeted Nanotherapeutics

Affiliations
Review

Smart Design of Nanomaterials for Mitochondria-Targeted Nanotherapeutics

Si Si Liew et al. Angew Chem Int Ed Engl. .

Abstract

Mitochondria are the powerhouse of cells. They are vital organelles that maintain cellular function and metabolism. Dysfunction of mitochondria results in various diseases with a great diversity of clinical appearances. In the past, strategies have been developed for fabricating subcellular-targeting drug-delivery nanocarriers, enabling cellular internalization and subsequent organelle localization. Of late, innovative strategies have emerged for the smart design of multifunctional nanocarriers. Hierarchical targeting enables nanocarriers to evade and overcome various barriers encountered upon in vivo administration to reach the organelle with good bioavailability. Stimuli-responsive nanocarriers allow controlled release of therapeutics to occur at the desired target site. Synergistic therapy can be achieved using a combination of approaches such as chemotherapy, gene and phototherapy. In this Review, we survey the field for recent developments and strategies used in the smart design of nanocarriers for mitochondria-targeted therapeutics. Existing challenges and unexplored therapeutic opportunities are also highlighted and discussed to inspire the next generation of mitochondrial-targeting nanotherapeutics.

Keywords: mitochondria; nanomaterials; nanotherapeutics; organelle-targeting; smart design.

PubMed Disclaimer

References

    1. None
    1. S. Fulda, L. Galluzzi, G. Kroemer, Nat. Rev. Drug Discovery 2010, 9, 447-464;
    1. J. Nunnari, A. Suomalainen, Cell 2012, 148, 1145-1159;
    1. G. S. Gorman, P. F. Chinnery, S. DiMauro, M. Hirano, Y. Koga, R. McFarland, A. Suomalainen, D. R. Thorburn, M. Zeviani, D. M. Turnbull, Nat. Rev. Dis. Primers 2016, 2, 16080;
    1. M. P. Murphy, R. C. Hartley, Nat. Rev. Drug Discovery 2018, 17, 865-886;

Publication types

LinkOut - more resources